Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers

Published:1998-03 Issue:3 Volume:63 Page:324-331
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Wong Shekman L.,Drajesk Jeffrey,Chang Min,Lanni Carmine,Witt Galen,Hansen Robert,Awni Walid M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference13 articles.

1. Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

2. 1 5-Lipoxygenase Inhibitors and their Anti-inflammatory Activities

3. Leukotrienes and Other Products of the 5-Lipoxygenase Pathway

4. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

5. Leukotrienes are potent constrictors of human bronchi

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A drug–drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5‐lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam;British Journal of Clinical Pharmacology;2024-06-03

2. Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery Disease;Journal of Medicinal Chemistry;2019-03-30

3. Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5-Lipoxygenase Activating Protein Inhibitor;Clinical and Translational Science;2018-03-08

4. A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome;Atherosclerosis;2015-05

5. Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis;Current Pharmaceutical Design;2009-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3